Oscar & Paul Beiersdorf Venture Capital

Hamburg, Germany
CVC
Active
Total investments

1

Average round size

40M

Portfolio companies

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth Care

Investor highlights

Industry focus
Climate techBiotech/Life SciencesHealthcareWellness & Fitness
Stage focus
Series A
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 40 more
Check size
536K — 3M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
1
Lead investments
0
Investments by industry
  • Health Care (1)
  • Biotechnology (1)
Investments by region
  • United States (1)
Peak activity year
2024

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Rubedo Life Sciences22 Apr 2024Biotechnology, Health CareEarly Stage Venture40MUnited States, California, Sunnyvale
Company nameDeal dateIndustryDeal stageDeal sizeLocation
Notable SystemsJan 4, 2025AI-driven Automation, Healthcare, Revenue Cycle Automation-12000000 USD Denver, Colorado
Roots AutomationSep 17, 2024AI, Banking, Healthcare, Insurance-22200000 USD New York
LevitateAug 29, 2024AI, Happiness Platform, Platform, Relationship-based businesses, Relationship-based Businesses, SaaSLate stage15000000 USD Raleigh, North Carolina
AdmiralAug 21, 20241st-party data innovations, AI-powered marketing automation, copyright access control, visitor relationship management-19000000 USD New York
ThreatXAug 17, 2022API protection, CybersecurityGrowth stage30000000 USD Boston, Massachusetts
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.